Orange Book product · Generic (ANDA)
AMINOCAPROIC ACID
AMINOCAPROIC ACID
At a glance
Nov 04, 2022
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 04, 2022
3 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
AMINOCAPROIC ACID
Strength
0.25GM/ML
Dosage form
SOLUTION
Route
ORAL
TE code
AA
Application
ANDA 216464
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of AMINOCAPROIC ACID
- 2004AMICARBrand (NDA)
NDA 015197 · HIKMA
- 1982AMINOCAPROIC ACIDBrand (NDA)
NDA 018590 · BAXTER HLTHCARE
- —AMICARBrand (NDA)
NDA 015229 · EPIC PHARMA LLC
- —AMICARBrand (NDA)
NDA 015230 · HIKMA
- 2025AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 215374 · ZENARA
- 2025AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213216 · SCIEGEN PHARMS
- 2024AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 215100 · MSN
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213213 · SUNNY
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 212938 · MSN
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 214458 · TARO
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 216804 · AUROBINDO PHARMA
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213944 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
